This retrospective study analyzed the frequency of systemic corticosteroid prescription before and after central serous chorioretinopathy (CSC) diagnosis. Source: AAO
This week, tocilizumab reduces the need for mechanical ventilation due to COVID-19, a gene therapy for dry AMD is fast-tracked by the FDA and Swiss scientists develop functional retinas in the lab. Source: AAO
This prospective longitudinal study characterized the morphologic and vascular changes in glaucomatous eyes. Source: AAO
This retrospective study evaluated the association between the use of 5α-reductase inhibitor (5-ARI) in men and macular abnormalities. Source: AAO
This case report describes corneal melt in a patient treated with topical interferon (INF) alpha 2b for conjunctival intraepithelial neoplasia (CIN) and carcinoma in situ of the cornea. Source: AAO
This week, Aldeyra Therapeutics gets clearance to test their drug for COVID-19, Oculus announces the new and improved Quest 2 VR headset and a common Parkinson drug shows promise for AMD. Source: AAO
This paper reports the 4-year outcomes of uncomplicated external dacryocystorhinostomy (DCR) with a 1-week intubation. Source: AAO
This study compared the diagnostic performance of an artificial intelligence deep learning system with that of expert neuro-ophthalmologists in classifying optic disc appearance. Source: AAO
Researchers evaluated the usefulness of repeat cultures after starting antifungal medication for predicting outcomes in fungal keratitis. Source: AAO
Researchers report the efficacy and safety of XEN45 at 2 years. Source: AAO